Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
2.320
-0.020 (-0.85%)
At close: Aug 14, 2026, 4:00 PM EDT
2.348
+0.028 (1.22%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Lexicon Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
41.4749.831.081.20.140.3
Revenue Growth
-29.03%60.24%2481.48%766.19%-53.36%-98.76%
Gross Profit
35.6743.2424.63-4.02-52.38-54.75
Operating Income
-54.5-48.91-196.02-171.75-100.46-87.09
Net Income
-61.12-50.34-200.4-177.12-101.94-87.76
Earnings Per Share
-0.16-0.14-0.63-0.80-0.62-0.60
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
190.6196.23237.96170.03138.3686.74
Total Debt
59.2462.24106.07106.0655.292.28
Net Cash (Debt)
131.3733.99131.8863.9683.0684.46
Net Cash Growth
69.31%-74.22%106.19%-23.00%-1.66%-39.44%
Net Cash Per Share
0.340.090.410.290.500.58

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-64.99-67.85-178.78-161.9-88.85-87.02
Capital Expenditures
---1.03-0.47-1.33-1.22
Free Cash Flow
-64.99-67.85-179.81-162.37-90.18-88.24
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
86.02%86.82%79.23%---
Operating Margin
-131.43%-98.21%-630.67%-14264.95%-72273.38%-29224.83%
Pretax Margin
-147.38%-101.08%-644.78%-14710.88%-73341.01%-29448.99%
Profit Margin
-147.38%-101.08%-644.78%-14710.88%-73341.01%-29448.99%
FCF Margin
-156.72%-136.24%-578.52%-13485.63%-64875.54%-29610.07%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-25.1725.1725.1725.1725.17
PS Ratio
24.898.398.59310.102593.281968.62